EBS logo

Emergent BioSolutions (EBS)

Profile

Full Name

Emergent BioSolutions Inc.

Ticker Symbol

EBS

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

November 15, 2006

Indexes

Not included

Website

http://www.emergentbiosolutions.com

Employees

900

Key Details

Price

$4.26(-9.17%)

Market cap

$231.48M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.01B(-0.92% YoY)

Annual EPS

-$3.60(+75.76% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.26
EBS price is $4.26

30-Day Relative Volume

0.51
EBS 30-day relative volume is 0.51

Price Performance

Price Most recent change

-9.17%
EBS price was down -9.17% on Apr 10, 2025

Price YTD change

-55.44%
EBS price is down -55.44% since January 1st

Price 1-year change

+94.52%
EBS price is up +94.52% year-on-year

Price 3-year change

-89.82%
EBS price is down -89.82% over the past 3 years

Price Range

Price All-time high

$137.61
EBS price is currently -96.90% below its historical high of $137.61

Price 3-year low

$1.42
EBS price is currently +200.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$231.48M
EBS market capitalization is $231.48 million

Market cap 3-year change

-89.02%
EBS market capitalization is down -89.02% over the past 3 years

Market cap All-time high

$7.14B
EBS market capitalization is currently -96.76% below its historical high of $7.14 billion

Market cap sector rank

60.48%
EBS market capitalization is higher than 60.48% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.7%
EBS shares outstanding is up +3.7% year-on-year

Shares Outstanding 3-Year Change

+7.81%
EBS shares outstanding is up +7.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.36
EBS beta is 2.36

200-day SMA

$8.65
EBS price is currently -50.75% below its 200-day simple moving average

50-day SMA

$6.94
EBS price is currently -38.63% below its 50-day simple moving average

RSI

32.28
EBS 14-day relative strength index is 32.28

Volume

0.51
EBS 30-day relative volume is 0.51

ATR

$0.49
EBS average true range is $0.49

10-day Historical Volatility

105.28%
EBS 10-day historical volatility is 105.28%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.01B
EBS annual revenue is $1.01 billion

Revenue Analysts estimate

$825.00M
EBS annual revenue is currently +22.86% higher than the consensus analysts' forecast

Revenue 1-year change

-0.92%
EBS annual revenue is down -0.92% year-on-year

Revenue Sector rank

80.29%
EBS annual revenue is higher than 80.29% of companies in Healthcare sector

EPS

EPS

-$3.60
EBS annual earnings per share is -$3.60

EPS Analysts estimate

$2.07
EBS annual earnings per share is currently -274.30% lower than the consensus analysts' forecast

EPS 1-year change

+75.76%
EBS annual earnings per share is up +75.76% year-on-year

EPS Sector rank

24.86%
EBS annual earnings per share is higher than 24.86% of companies in Healthcare sector

Profit

Gross profit

$332.30M
EBS annual gross profit is $332.30 million

Gross margin

32.78%
EBS annual gross profit margin is 32.78%

Operating profit

-$81.50M
EBS annual operating income is -$81.50 million

Operating margin

-8.04%
EBS annual operating profit margin is -8.04%

Net income

-$190.60M
EBS annual net profit is -$190.60 million

Net margin

-18.80%
EBS annual net profit margin is -18.80%

Expenses

Total expenses

$1.10B
EBS annual total expenses is $1.10 billion

Operating expenses

$413.80M
EBS annual total operating expenses is $413.80 million

Cost of goods sold

$681.30M
EBS annual cost of goods sold is $681.30 million

Selling, general & administrative expenses

$308.00M
EBS annual SGA is $308.00 million

Depreciation and amortization

$108.80M
EBS annual depreciation & amortization is $108.80 million

Interest expense

$71.00M
EBS annual interest expense is $71.00 million

Income tax

$47.70M
EBS annual income tax is $47.70 million

EBIT & EBITDA

EBIT

-$71.90M
EBS annual earnings before interest & taxes is -$71.90 million

EBITDA

$36.90M
EBS annual EBITDA is $36.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.39B
EBS annual total assets is $1.39 billion

Non current assets

$791.00M
EBS annual long term assets is $791.00 million

Current assets

$598.70M
EBS annual total current assets is $598.70 million

Cash and cash equivalents

$99.50M
EBS annual cash & cash equivalents is $99.50 million

Accounts receivable

$135.40M
EBS annual accounts receivable is $135.40 million

Inventory

$311.70M
EBS annual inventory is $311.70 million

Liabilities

Total liabilities

$906.90M
EBS annual total liabilities is $906.90 million

Long term liabilities

$744.50M
EBS annual total long term liabilities is $744.50 million

Current liabilities

$162.40M
EBS annual total current liabilities is $162.40 million

Accounts payable

$60.90M
EBS annual accounts payable is $60.90 million

Debt

Total debt

$663.70M
EBS annual total debt is $663.70 million

Total debt 1-year change

-22.84%
EBS annual total debt is down -22.84% year-on-year

Long term debt

$663.70M
EBS annual long term debt is $663.70 million

Short term debt

-
EBS annual short term debt value is unknown

Equity & Capital

Shareholders equity

$482.80M
EBS annual stockholders equity is $482.80 million

Book value

$482.80M
EBS annual book value is $482.80 million

Retained earnings

-$212.40M
EBS annual retained earnings is -$212.40 million

Working capital

$436.30M
EBS annual working capital is $436.30 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$58.70M
EBS annual cash flow from operations is $58.70 million

Cash from operations 1-year change

+128.45%
EBS annual cash flow from operations is up +128.45% year-on-year

Cash from investing

$125.20M
EBS annual cash flow from investing activities is $125.20 million

Cash from investing 1-year change

-41.03%
EBS annual cash flow from investing activities is down -41.03% year-on-year

Cash from financing

-$190.00M
EBS annual cash flow from financing activities is -$190.00 million

Cash from financing 1-year change

+64.53%
EBS annual cash flow from financing activities is up +64.53% year-on-year

CAPEX

CAPEX

$22.90M
EBS annual capital expenditures is $22.90 million

CAPEX 1-year change

-55.62%
EBS annual capital expenditures is down -55.62% year-on-year

Free Cash Flow

Free cash flow

$35.80M
EBS annual free cash flow is $35.80 million

Free cash flow 1-year change

+113.88%
EBS annual free cash flow is up +113.88% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

32.78%
EBS annual gross profit margin is 32.78%

Operating margin

-8.04%
EBS annual operating profit margin is -8.04%

Net margin

-18.80%
EBS annual net profit margin is -18.80%

ROA & ROE

ROA

-11.86%
EBS annual return on assets is -11.86%

ROE

-33.67%
EBS annual return on equity is -33.67%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EBS price to earnings ratio value is unknown

PE ratio Sector rank

-
EBS price to earnings ratio is unknown

PB Ratio

PB ratio

0.48
EBS price to book ratio is 0.48

PB ratio Sector rank

30.26%
EBS price to book ratio is higher than 30.26% of companies in Healthcare sector

PS Ratio

PS ratio

0.23
EBS price to sales ratio is 0.23

PS ratio Sector rank

8.33%
EBS price to sales ratio is higher than 8.33% of companies in Healthcare sector

Enterprise value

Enterprise value

$795.68M
EBS enterprise value is $795.68 million

Enterprise value Sector rank

74.53%
EBS enterprise value is higher than 74.53% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

21.56
EBS EV/EBITDA is 21.56

EV/EBITDA Sector rank

92.71%
EBS EV/EBITDA is higher than 92.71% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.69
EBS annual current ratio is 3.69

Quick ratio

1.77
EBS annual quick ratio is 1.77

Leverage

Debt to equity

1.37
EBS annual debt to equity ratio is 1.37

Interest coverage ratio

-1.01
EBS annual interest coverage ratio is -1.01

Risk & Stability

Piotroski F-Score

5
EBS piotroski f-score is 5

Altman Z-Score

0.87
EBS altman z-score is 0.87

Analyst ratings

Recent major analysts updates

Apr 1, 25 HC Wainwright & Co.
Buy
Mar 21, 25 HC Wainwright & Co.
Buy
Mar 4, 25 HC Wainwright & Co.
Buy
Jan 21, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Dec 30, 24 HC Wainwright & Co.
Buy
Nov 7, 24 Benchmark
Buy
Sep 13, 24 Rodman & Renshaw
Buy
Aug 22, 24 Rodman & Renshaw
Buy
Aug 16, 24 Benchmark
Buy

Institutional Ownership

Similar stocks

CERS logo
Cerus (CERS)
VSTM logo
Verastem (VSTM)
AVIR logo
Atea Pharmaceuticals (AVIR)
OLMA logo
Olema Pharmaceuticals (OLMA)
Septerna (SEPN)
ATXS logo
Astria Therapeutics (ATXS)
CMPX logo
Compass Therapeutics (CMPX)
RCEL logo
AVITA Medical (RCEL)
XOMA logo
XOMA (XOMA)
  • What is the ticker symbol for Emergent BioSolutions?
  • Does Emergent BioSolutions pay dividends?
  • What sector is Emergent BioSolutions in?
  • What industry is Emergent BioSolutions in?
  • What country is Emergent BioSolutions based in?
  • When did Emergent BioSolutions go public?
  • Is Emergent BioSolutions in the S&P 500?
  • Is Emergent BioSolutions in the NASDAQ 100?
  • Is Emergent BioSolutions in the Dow Jones?
  • When was Emergent BioSolutions's last earnings report?
  • When does Emergent BioSolutions report earnings?
  • Should I buy Emergent BioSolutions stock now?

What is the ticker symbol for Emergent BioSolutions?

The ticker symbol for Emergent BioSolutions is NYSE:EBS

Does Emergent BioSolutions pay dividends?

No, Emergent BioSolutions does not pay dividends

What sector is Emergent BioSolutions in?

Emergent BioSolutions is in the Healthcare sector

What industry is Emergent BioSolutions in?

Emergent BioSolutions is in the Drug Manufacturers - Specialty & Generic industry

What country is Emergent BioSolutions based in?

Emergent BioSolutions is headquartered in United States

When did Emergent BioSolutions go public?

Emergent BioSolutions's initial public offering (IPO) was on November 15, 2006

Is Emergent BioSolutions in the S&P 500?

No, Emergent BioSolutions is not included in the S&P 500 index

Is Emergent BioSolutions in the NASDAQ 100?

No, Emergent BioSolutions is not included in the NASDAQ 100 index

Is Emergent BioSolutions in the Dow Jones?

No, Emergent BioSolutions is not included in the Dow Jones index

When was Emergent BioSolutions's last earnings report?

Emergent BioSolutions's most recent earnings report was on Mar 3, 2025

When does Emergent BioSolutions report earnings?

The next expected earnings date for Emergent BioSolutions is May 1, 2025

Should I buy Emergent BioSolutions stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page